Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Elicio Therapeutics, Inc. (ELTX) had Pre-Tax Income of $-8.22M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-8.22M |
|
-- |
|
-- |
|
$10.43M |
|
$-10.43M |
|
$2.21M |
|
|
Pre-Tax Income |
$-8.22M |
$-8.22M |
|
$-8.22M |
|
$-8.22M |
|
$-8.22M |
|
$-8.22M |
|
$-10.43M |
|
$-10.09M |
|
19.24M |
|
19.24M |
|
$-0.43 |
|
$-0.43 |
|
| Balance Sheet Financials | |
$25.48M |
|
$0.21M |
|
$5.84M |
|
$31.33M |
|
$9.20M |
|
$9.54M |
|
$14.19M |
|
$23.39M |
|
$7.94M |
|
$7.94M |
|
$7.94M |
|
21.90M |
|
| Cash Flow Statement Financials | |
$-19.81M |
|
-- |
|
$24.54M |
|
$19.27M |
|
$24.00M |
|
$4.73M |
|
$1.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.77 |
|
-- |
|
-- |
|
0.55 |
|
1.20 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.81M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-103.53% |
|
-103.53% |
|
-26.23% |
|
-47.03% |
|
$0.36 |
|
$-1.03 |
|
$-1.03 |
|